Xiao-Bing Wang (Xiaobing Wang)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Venues

Journal of medicinal chemistry

Organic letters

RSC advances

Chemistry (Weinheim an der Bergstrasse, Germany)

China Pharmaceutical University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

China Pharmaceutical University Jun 15 2017

China

Professor

China Pharmaceutical University Jun 15 2011 - Jun 15 2017

China

Associate Professor :: Department of Natural Medicinal Chemistry

Publications

Fucheng Yin, Yifan Chen, Zhongwen Luo, Shang Li, Yonglei Zhang, Siyuan Wan, Xinxin Li, Ling-Yi Kong, Xiao-Bing Wang
Regioselective Olefination and Arylation of Arene-Tethered Diols Using the Easily Foldable Directing Groups. Organic letters 26 (7) (2024)
Fucheng Yin, Lailiang Qu, Yifan Chen, Zhongwen Luo, Lingyi Kong, Xiao-Bing Wang
Stereoselective Synthesis of β, γ-Fused Bicyclic γ-Ureasultams via an Intramolecular Mannich and aza-Michael Addition Cascade. Chemistry (Weinheim an der Bergstrasse, Germany) (2024)
Fucheng Yin, Yifan Chen, Zhongwen Luo, Shang Li, Yonglei Zhang, Siyuan Wan, Xinxin Li, Ling-Yi Kong, Xiao-Bing Wang
Regioselective Olefination and Arylation of Arene-Tethered Diols Using the Easily Foldable Directing Groups. Organic letters (2024)
Shang Li, Liangliang Ma, Xinxin Li, Yuhan Jiang, Zhongwen Luo, Fucheng Yin, Yonglei Zhang, Yifan Chen, Siyuan Wan, Han Zhou, Ling-Yi Kong, Xiao-Bing Wang
Discovery of Covalent MLKL PROTAC Degraders via Optimization of a Theophylline Derivative Ligand for Treating Necroptosis. Journal of medicinal chemistry (2024)
Fucheng Yin, Lailiang Qu, Yifan Chen, Zhongwen Luo, Lingyi Kong, Xiao-Bing Wang
Stereoselective Synthesis of β, γ-Fused Bicyclic γ-Ureasultams via an Intramolecular Mannich and aza-Michael Addition Cascade. Chemistry (Weinheim an der Bergstrasse, Germany) 30 (28) (2024)
Panhu Zhu, Tao Zhou, Hong Chen, Xingru Chen, Xiao-Bing Wang, Ling-Yi Kong, Ming-Hua Yang
Novel Triazoles with Potent and Broad-Spectrum Antifungal Activity In Vitro and In Vivo. Journal of medicinal chemistry (2023)
Fucheng Yin, Yifan Chen, Zhongwen Luo, Shang Li, Ling-Yi Kong, Xiao-Bing Wang
Aryl Halides as Halogenation Reagents in the Bromination and Iodination of Arene-Tethered Diols. Organic letters 24 (36) (2022)
Dehua Lu, Cheng Wang, Lailiang Qu, Fucheng Yin, Shang Li, Heng Luo, Yonglei Zhang, Xingchen Liu, Xinye Chen, Zhongwen Luo, Ningjie Cui, Ling-Yi Kong, Xiao-Bing Wang
Histone Deacetylase and Enhancer of Zeste Homologue 2 Dual Inhibitors Presenting a Synergistic Effect for the Treatment of Hematological Malignancies. Journal of medicinal chemistry 65 (19) (2022)
Jiafu Leng, Yongjun Zhao, Ping Sheng, Yuanzheng Xia, Tingting Chen, Shifang Zhao, Shanshan Xie, Xiangyu Yan, Xiao-Bing Wang, Yong Yin, Ling-Yi Kong
Discovery of Novel N -Heterocyclic-Fused Deoxypodophyllotoxin Analogues as Tubulin Polymerization Inhibitors Targeting the Colchicine-Binding Site for Cancer Treatment. Journal of medicinal chemistry (2022)
Peng-Ran Cao, Yi-Lei Zheng, Yong-Qin Zhao, Xiao-Bing Wang, Hao Zhang, Mei-Hui Zhang, Ting Yang, Yu-Cheng Gu, Ming-Hua Yang, Ling-Yi Kong
Beetleane A and Epicoane A: Two Carbon Skeletons Produced by Epicoccum nigrum. Organic letters 23 (9) (2021)
Wan Peng, Qiaohong Liu, Fucheng Yin, Cunjian Shi, Limei Ji, Lailiang Qu, Cheng Wang, Heng Luo, Ling-Yi Kong, Xiao-Bing Wang
Rhodium(iii) catalyzed olefination and deuteration of tetrahydrocarbazole. RSC advances 11 (14) (2021)
Cheng Wang, Lailiang Qu, Shang Li, Fucheng Yin, Limei Ji, Wan Peng, Heng Luo, Dehua Lu, Xingchen Liu, Xinye Chen, Ling-Yi Kong, Xiao-Bing Wang
Discovery of First-in-Class Dual PARP and EZH2 Inhibitors for Triple-Negative Breast Cancer with Wild-Type BRCA. Journal of medicinal chemistry 64 (17) (2021)
Xingchen Liu, Cheng Wang, Shang Li, Lailiang Qu, Fucheng Yin, Dehua Lu, Heng Luo, Xinye Chen, Zhongwen Luo, Ningjie Cui, Xiao-Bing Wang, Ling-Yi Kong
Parthenolide Derivatives as PKM2 Activators Showing Potential in Colorectal Cancer. Journal of medicinal chemistry 64 (23) (2021)
Jinhua Zhao, Fucheng Yin, Limei Ji, Cheng Wang, Cunjian Shi, Xingchen Liu, Huali Yang, Xiao-Bing Wang, Ling-Yi Kong
Development of a Tau-Targeted Drug Delivery System Using a Multifunctional Nanoscale Metal-Organic Framework for Alzheimer's Disease Therapy. ACS applied materials & interfaces 12 (40) (2020)
Xiao-Bing Wang, Fu-Cheng Yin, Ming Huang, Neng Jiang, Jin-Shuai Lan, Ling-Yi Kong
Chromone and donepezil hybrids as new multipotent cholinesterase and monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease. RSC medicinal chemistry 11 (2) (2020)
Cheng Wang, Shang Li, Jinhua Zhao, Huali Yang, Fucheng Yin, Ming Ding, Jianguang Luo, Xiao-Bing Wang, Ling-Yi Kong
Design and SAR of Withangulatin A Analogues that Act as Covalent TrxR Inhibitors through the Michael Addition Reaction Showing Potential in Cancer Treatment. Journal of medicinal chemistry 63 (19) (2020)
Hong Zhang, Ming-Hua Yang, Fang-Fang Zhuo, Na Gao, Xiao-Bei Cheng, Xiao-Bing Wang, Yue-Hu Pei, Ling-Yi Kong
Seven new cytotoxic phenylspirodrimane derivatives from the endophytic fungus Stachybotrys chartarum . RSC advances 9 (7) (2019)
Siqiang Fang, Xiao-Bing Wang, Fucheng Yin, Pei Cai, Huali Yang, Ling-Yi Kong
Palladium-Catalyzed meta-C-H Olefination of Arene-Tethered Diols Directed by Well-Designed Pyrimidine-Based Group. Organic letters 21 (6) (2019)
Dong-Mei Sun, Fa-Liang An, Shan-Shan Wei, Yan-Qiu Zhang, Xiao-Bing Wang, Jun Luo, Ling-Yi Kong
Cipadessains A-K, eleven limonoids from the fruits of Cipadessa cinerascens . RSC advances 8 (19) (2018)
Tian-Xiao Li, Rui-Huan Liu, Xiao-Bing Wang, Jun Luo, Jian-Guang Luo, Ling-Yi Kong, Ming-Hua Yang
Hypoxia-Protective Azaphilone Adducts from Peyronellaea glomerata. Journal of natural products 81 (5) (2018)
Qiao-Hong Liu, Jia-Jia Wu, Fan Li, Pei Cai, Xue-Lian Yang, Ling-Yi Kong, Xiao-Bing Wang
Synthesis and pharmacological evaluation of multi-functional homoisoflavonoid derivatives as potent inhibitors of monoamine oxidase B and cholinesterase for the treatment of Alzheimer's disease. MedChemComm 8 (7) (2017)

Xiao-Bing Wang.css-eqlu8i{font-size:small;padding-left:4px;} (Xiaobing Wang)

Publication Activity (10 Years)

Top Topics

Top Venues

Xiao-Bing Wang (Xiaobing Wang)